Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ovid Therapeutics (OVID) Depreciation & Amortization (CF) (2016 - 2026)

Ovid Therapeutics filings provide 11 years of Depreciation & Amortization (CF) readings, the most recent being $35000.0 for Q1 2026.

  • Quarterly Depreciation & Amortization (CF) fell 75.18% to $35000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $167000.0 through Mar 2026, down 72.98% year-over-year, with the annual reading at $273000.0 for FY2025, 55.46% down from the prior year.
  • Depreciation & Amortization (CF) hit $35000.0 in Q1 2026 for Ovid Therapeutics, up from $17000.0 in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $184980.0 in Q4 2022 and bottomed at $16000.0 in Q3 2025.
  • Average Depreciation & Amortization (CF) over 5 years is $117735.6, with a median of $140000.0 recorded in 2023.
  • The largest annual shift saw Depreciation & Amortization (CF) skyrocketed 224.81% in 2022 before it plummeted 90.53% in 2025.
  • Ovid Therapeutics' Depreciation & Amortization (CF) stood at $184980.0 in 2022, then decreased by 24.32% to $140000.0 in 2023, then rose by 14.29% to $160000.0 in 2024, then tumbled by 89.38% to $17000.0 in 2025, then surged by 105.88% to $35000.0 in 2026.
  • Per Business Quant, the three most recent readings for OVID's Depreciation & Amortization (CF) are $35000.0 (Q1 2026), $17000.0 (Q4 2025), and $16000.0 (Q3 2025).